Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study

BACKGROUND: Aspirin has been found to lower the occurrence rates of some cancers through the inhibition of the cyclooxygenase enzyme. For example, there is a well-known association between aspirin use and the occurrence of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) carriers. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yen-Hsiang, Hsu, Ren-Jun, Wang, Tzu-Hwei, Wu, Chen-Ta, Huang, Sheng-Yao, Hsu, Chung-Y., Su, Yuan-Chih, Hsu, Wen-Lin, Liu, Dai-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953130/
https://www.ncbi.nlm.nih.gov/pubmed/31918672
http://dx.doi.org/10.1186/s12876-020-1158-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953130/
https://www.ncbi.nlm.nih.gov/pubmed/31918672
http://dx.doi.org/10.1186/s12876-020-1158-y

Ejemplares similares